Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4953150012 | Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4953151011 | Methoxy polyethylene glycol-epoetin beta only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Is a | Methoxy polyethylene glycol-epoetin beta only product | true | Inferred relationship | Some | ||
| Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Is a | Product containing methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Is a | Epoetin beta only product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Has active ingredient | Methoxy polyethylene glycol-epoetin beta (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection | Is a | True | Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection | Is a | True | Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection | Is a | True | Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection | Is a | True | Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
FHIR